IL6 and neoplasm: The expression levels of pro-inflammatory and tumor-related genes, including VEGF, MMP9, TGF-β, TNF-α, COX-2, PGE2, and IL-6, were significantly downregulated in a dose-dependent manner following treatment with ATD-PLGA NPs compared to the untreated group.